- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05754723
Using an Online Psychotherapy Program and AI-assisted Interventions for Postsecondary Student Mental Health
Developing, Administering, and Evaluating Online Psychotherapy and Psychoeducation Programs for Postsecondary Students Within a Regional Mental Health Hub in Ontario, Canada Using AI-assisted Online Interventions
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The proposed regional mental healthcare hub aims to deliver equitable, efficacious, and cost-effective AI-driven online psychoeducation and diagnosis-specific online cognitive behavioural therapy (e-CBT) programs for post-secondary students in the Kingston, Frontenac, Lennox & Addington (KFL&A) region. The initiative will target a broad population of students ranging from those interested in learning more about mental health (online psychoeducation program) to those seeking additional help for their psychiatric symptoms (e-CBT program). Our research team is strongly experienced in designing effective AI-assisted online psychoeducation and diagnosis-specific e-CBT programs for various mental health conditions in diverse populations. Therefore, being as effective as in-person methods of healthcare delivery, it is hypothesized that our online interventions disseminated via a robust implementation science and community collaboration strategy will be a feasible, cost-effective, and pragmatic solution to address accessibility issues with post-secondary student mental healthcare.
The proposed mental health hub will offer a comprehensive care model using a stepped-care approach. Its implementation will be guided by a rigorous approach involving seven aims divided into three phases (pre-adoption, delivery, and post-adoption phases). (1) Pre-adoption phase: will assess post-secondary students' current mental health landscape through surveys and focus groups (Aim 1). This information will be used in the development of a 6-week online psychoeducation (Aim 2) and 12-week diagnosis-specific e-CBT (Aim 3) programs. The psychoeducation program will be followed by 6-months of AI-assisted journaling exercises to monitor the student's mental health and determine whether they would benefit from stepping up their care to receive the diagnosis-specific e-CBT program. The diagnosis-specific e-CBT programs will be adapted from prior clinically validated and diagnosis-specific psychotherapy modules developed by the lab. Four diagnosis-specific modules will support the most common mental health disorders in students (GAD, SAD, MDD and ADHD), as indicated by previous studies and the research team's cross-sectional survey of students in Ontario, Canada. Both programs will be delivered through the Online Psychotherapy Tool (OPTT) - a secure cloud-based platform co-developed by the PI that offers online mental health interventions. (2) Delivery phase: will determine the efficacy and cost-effectiveness of the online psychoeducation (Aim 4) and diagnosis-specific e-CBT (Aim 5) programs by comparing them to treatment, as usual, using validated clinical assessment tools. (3) Post-adoption phase: will use the collected data to monitor the success and fidelity of the programs using surveys and focus groups (Aim 6), and to build capacity and scale the project to other Canadian municipalities (Aim 7). As such, in contrast to other initiatives that target student mental health, this will be the first to involve students and end-users in all phases, from conception to implementation.
The digital nature of this healthcare program and the implementation of AI technology results in new solutions that enable easier accessibility and broader reach to individuals in significant need of mental healthcare services. Therefore, to support the development of these mental healthcare resources, the research team has assembled a diverse, cross-functional interdisciplinary team of community leaders, including researchers, clinicians, health decision-makers, and end-users. Ultimately, leveraging the extensive expertise of a cross-functional research team, the objective of the study is to develop and implement a successful and effective digital care plan with the potential to improve post-secondary student mental health care substantially.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Kingston, Ontario, Canada, K7L 3N6
- Queen's University, Hotel Dieu Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- post-secondary students enrolled in institutions of interest
- the ability to provide informed consent
- the ability to speak and read English
- consistent and reliable access to the internet
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: e-Psychotherapy
Participants in the treatment group will receive access to the hub's services which begin with six weeks of online psychoeducation.
Participants will be recruited through on-campus flyers, advertisements and wellness-center announcements, media advertisements, expert end-user referrals, and self-referrals.
Participants will be excluded if they have active psychosis, acute mania, and/or active suicidal or homicidal ideation, and have received psychoeducation or psychotherapy like that offered by our proposed hub in the past six months.
Participants with high disorder severity will be referred to other community resources determined by clinicians and therapists on the research team.
|
Participants will receive six weekly self-guided psychoeducation sessions.
Then, after 6 weeks participants will complete monthly clinical questionnaires for 6 months.
Also, participants will begin bi-weekly journaling exercises for 6 months.
Based on the journaling entries, if the AI algorithm detects MDD, GAD, SAD or ADHD that requires treatment will make a referral to the diagnosis-specific e-CBT (MDD, GAD, SAD or ADHD).
If after 6 months, no referral decision is made by the AI algorithm no extra follow-up will be provided.
Once the AI makes a referral recommendation, participants will be placed in a diagnosis-specific e-CBT program specific to the diagnosis determined by the AI algorithm (MDD, GAD, SAD, or ADHD).
The asynchronous e-CBT programs will consist of 12 weekly modules and homework.
Weekly homework is reviewed by a therapist, who will provide personalized feedback based on the participant's preferred method (i.e., text, video, or audio).
|
|
No Intervention: Treatment as Usual
TAU will consist of medications, regular physician or clinician visits, referrals or consultations that are conducted outside of the current research study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in anxiety severity (GAD-7)
Time Frame: weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
Generalized anxiety disorder - 7 item (GAD-7) questionnaire.
Increase in score dictates increase in severity.
Scale of 0-3
|
weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
|
Change in depression severity (PHQ-9)
Time Frame: weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
Patient Health Questionnaire - 9 item (PHQ-9).
Increase in score dictates increase in severity.
Scale of 0-3 on each question.
|
weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
|
Change in depression severity (QIDS)
Time Frame: weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
Quick Inventory of Depressive Symptomatology (QIDS).
Increase in score dictates increase in severity.
Scale of 0-3 on each question
|
weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
|
Change in stress severity (DASS-42)
Time Frame: weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
Depression Anxiety Stress Scale-42 (DASS-42).
Increase in score dictates increase in severity.
Scale of 0-3 on each question.
|
weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
|
Change in quality of life (AQoL-8D)
Time Frame: weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
Assessment of Quality of Life-8D (AQoL-8D).
Increase in score dictates increase in quality of life (improvement).
Scale of 0-5 on each question.
|
weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
|
Change in resilience (RS-14)
Time Frame: weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
Resilience Scale-14 (RS-14).
Increase in score dictates increase in resilience (improvement).
Scale of 0-7 on each question
|
weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
|
Change in social anxiety severity (LSAS)
Time Frame: weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
Liebowitz Social Anxiety Scale (LSAS).
Increase in score dictates increase in anxiety severity.
Scale of 0-3 on each question.
|
weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
|
Change in ADHD severity (ASRS)
Time Frame: weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
Adult ADHD Self-Report Scale (ASRS).
Increase in score dictates increase in ADHD symptom severity.
Scale of 0-5 on each question.
|
weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nazanin Alavi, MD, Queen's University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 6034514
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Issue
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
Stanford UniversityRecruitingMental Health IssueUnited States
-
The Hong Kong Polytechnic UniversityRecruiting
-
Yale UniversityEmpowerment to Heal - Uganda; Empower Through HealthRecruiting
-
The Hong Kong Polytechnic UniversityRecruiting
-
Hospices Civils de LyonCompleted
-
The Hong Kong Polytechnic UniversityCompleted
-
Limbic LimitedCompletedMental Health IssueUnited Kingdom
-
Babes-Bolyai UniversityThe Executive Agency for Higher Education, Research, Development and Innovation...Completed
-
Wake Forest University Health SciencesThe Duke EndowmentCompletedMental Health IssueUnited States
Clinical Trials on e-Psychotherapy/Psychoeducation
-
Ospedale Amedeo di SavoiaUnknown
-
University of CagliariAlessandra PerraCompletedBipolar Disorder | COVID-19 Pandemic | PsychoeducationItaly
-
Dr. Nazanin AlaviOnline PsychoTherapy ClinicCompletedDepression | Covid19 | Anxiety Disorders | Mental Health IssueCanada
-
Dr. Kübra Gülırmak GülerThe Scientific and Technological Research Council of TurkeyCompletedNurse Well-beingTurkey (Türkiye)
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)RecruitingDepressive Disorder | Depression | Suicidal Ideation | Major Depressive DisorderUnited States
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)CompletedSocial Reward and Its Effect on Brain Functions in Psychotherapies for Mid- and Late-Life DepressionMajor Depressive DisorderUnited States
-
Weill Medical College of Cornell UniversityRecruiting
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Muğla Sıtkı Koçman UniversityCompletedTherapy, Directly ObservedTurkey (Türkiye)
-
Florida State UniversityRecruitingPain | Chronic Pain | Acute Pain | Pain ManagementUnited States